WNK1
Serine/threonine-protein kinase WNK1
Also known as: HSAN2, HSN2, PPP1R167, PRKWNK1, WNK1_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9H4A3
- Gene
- WNK1
- Ensembl
- ENSG00000060237
- Chromosome
- 12
- Canonical length
- 2382 aa
- Protein class
- Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins
- Subcellular location
- Cytosol
OverviewNCBI Gene
This gene encodes a member of the WNK subfamily of serine/threonine protein kinases. The encoded protein may be a key regulator of blood pressure by controlling the transport of sodium and chloride ions. Mutations in this gene have been associated with pseudohypoaldosteronism type II and hereditary sensory neuropathy type II. Alternatively spliced transcript variants encoding different isoforms have been described but the full-length nature of all of them has yet to be determined.[provided by RefSeq, May 2010]
Canonical amino-acid sequenceUniProt
2382 residues, UniProt reviewed canonical sequence.
>Q9H4A3|WNK1
1 MSGGAAEKQS STPGSLFLSP PAPAPKNGSS SDSSVGEKLG AAAADAVTGR TEEYRRRRHT
61 MDKDSRGAAA TTTTTEHRFF RRSVICDSNA TALELPGLPL SLPQPSIPAA VPQSAPPEPH
121 REETVTATAT SQVAQQPPAA AAPGEQAVAG PAPSTVPSST SKDRPVSQPS LVGSKEEPPP
181 ARSGSGGGSA KEPQEERSQQ QDDIEELETK AVGMSNDGRF LKFDIEIGRG SFKTVYKGLD
241 TETTVEVAWC ELQDRKLTKS ERQRFKEEAE MLKGLQHPNI VRFYDSWEST VKGKKCIVLV
301 TELMTSGTLK TYLKRFKVMK IKVLRSWCRQ ILKGLQFLHT RTPPIIHRDL KCDNIFITGP
361 TGSVKIGDLG LATLKRASFA KSVIGTPEFM APEMYEEKYD ESVDVYAFGM CMLEMATSEY
421 PYSECQNAAQ IYRRVTSGVK PASFDKVAIP EVKEIIEGCI RQNKDERYSI KDLLNHAFFQ
481 EETGVRVELA EEDDGEKIAI KLWLRIEDIK KLKGKYKDNE AIEFSFDLER DVPEDVAQEM
541 VESGYVCEGD HKTMAKAIKD RVSLIKRKRE QRQLVREEQE KKKQEESSLK QQVEQSSASQ
601 TGIKQLPSAS TGIPTASTTS ASVSTQVEPE EPEADQHQQL QYQQPSISVL SDGTVDSGQG
661 SSVFTESRVS SQQTVSYGSQ HEQAHSTGTV PGHIPSTVQA QSQPHGVYPP SSVAQGQSQG
721 QPSSSSLTGV SSSQPIQHPQ QQQGIQQTAP PQQTVQYSLS QTSTSSEATT AQPVSQPQAP
781 QVLPQVSAGK QLPVSQPVPT IQGEPQIPVA TQPSVVPVHS GAHFLPVGQP LPTPLLPQYP
841 VSQIPISTPH VSTAQTGFSS LPITMAAGIT QPLLTLASSA TTAAIPGVST VVPSQLPTLL
901 QPVTQLPSQV HPQLLQPAVQ SMGIPANLGQ AAEVPLSSGD VLYQGFPPRL PPQYPGDSNI
961 APSSNVASVC IHSTVLSPPM PTEVLATPGY FPTVVQPYVE SNLLVPMGGV GGQVQVSQPG
1021 GSLAQAPTTS SQQAVLESTQ GVSQVAPAEP VAVAQTQATQ PTTLASSVDS AHSDVASGMS
1081 DGNENVPSSS GRHEGRTTKR HYRKSVRSRS RHEKTSRPKL RILNVSNKGD RVVECQLETH
1141 NRKMVTFKFD LDGDNPEEIA TIMVNNDFIL AIERESFVDQ VREIIEKADE MLSEDVSVEP
1201 EGDQGLESLQ GKDDYGFSGS QKLEGEFKQP IPASSMPQQI GIPTSSLTQV VHSAGRRFIV
1261 SPVPESRLRE SKVFPSEITD TVAASTAQSP GMNLSHSASS LSLQQAFSEL RRAQMTEGPN
1321 TAPPNFSHTG PTFPVVPPFL SSIAGVPTTA AATAPVPATS SPPNDISTSV IQSEVTVPTE
1381 EGIAGVATST GVVTSGGLPI PPVSESPVLS SVVSSITIPA VVSISTTSPS LQVPTSTSEI
1441 VVSSTALYPS VTVSATSASA GGSTATPGPK PPAVVSQQAA GSTTVGATLT SVSTTTSFPS
1501 TASQLCIQLS SSTSTPTLAE TVVVSAHSLD KTSHSSTTGL AFSLSAPSSS SSPGAGVSSY
1561 ISQPGGLHPL VIPSVIASTP ILPQAAGPTS TPLLPQVPSI PPLVQPVANV PAVQQTLIHS
1621 QPQPALLPNQ PHTHCPEVDS DTQPKAPGID DIKTLEEKLR SLFSEHSSSG AQHASVSLET
1681 SLVIESTVTP GIPTTAVAPS KLLTSTTSTC LPPTNLPLGT VALPVTPVVT PGQVSTPVST
1741 TTSGVKPGTA PSKPPLTKAP VLPVGTELPA GTLPSEQLPP FPGPSLTQSQ QPLEDLDAQL
1801 RRTLSPEMIT VTSAVGPVSM AAPTAITEAG TQPQKGVSQV KEGPVLATSS GAGVFKMGRF
1861 QVSVAADGAQ KEGKNKSEDA KSVHFESSTS ESSVLSSSSP ESTLVKPEPN GITIPGISSD
1921 VPESAHKTTA SEAKSDTGQP TKVGRFQVTT TANKVGRFSV SKTEDKITDT KKEGPVASPP
1981 FMDLEQAVLP AVIPKKEKPE LSEPSHLNGP SSDPEAAFLS RDVDDGSGSP HSPHQLSSKS
2041 LPSQNLSQSL SNSFNSSYMS SDNESDIEDE DLKLELRRLR DKHLKEIQDL QSRQKHEIES
2101 LYTKLGKVPP AVIIPPAAPL SGRRRRPTKS KGSKSSRSSS LGNKSPQLSG NLSGQSAASV
2161 LHPQQTLHPP GNIPESGQNQ LLQPLKPSPS SDNLYSAFTS DGAISVPSLS APGQGTSSTN
2221 TVGATVNSQA AQAQPPAMTS SRKGTFTDDL HKLVDNWARD AMNLSGRRGS KGHMNYEGPG
2281 MARKFSAPGQ LCISMTSNLG GSAPISAASA TSLGHFTKSM CPPQQYGFPA TPFGAQWSGT
2341 GGPAPQPLGQ FQPVGTASLQ NFNISNLQKS ISNPPGSNLR TTLocalizationUniProt · AlphaFold · HPA
Whether an antibody against WNK1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.59
- Highest tissue expression
- 165 nTPM
Expression across tissuesHPA
Tissue
- spinal cord: 165 nTPM
- midbrain: 124 nTPM
- hippocampal formation: 93 nTPM
- amygdala: 88 nTPM
- retina: 81 nTPM
- basal ganglia: 80 nTPM
Single-cell type
- distal convoluted tubule cells: 1,796 nCPM
- renal connecting tubule cells: 893 nCPM
- esophageal apical cells: 826 nCPM
- neutrophils: 604 nCPM
- cardiomyocytes: 603 nCPM
- neutrophil progenitors: 446 nCPM
Immune cell
- neutrophil: 5.6 nTPM
- non-classical monocyte: 4.8 nTPM
- T-reg: 3.4 nTPM
- intermediate monocyte: 2.1 nTPM
- memory CD8 T-cell: 2.1 nTPM
- classical monocyte: 1.9 nTPM
Brain region
- white matter: 693 nTPM
- midbrain: 591 nTPM
- thalamus: 586 nTPM
- medulla oblongata: 585 nTPM
- basal ganglia: 580 nTPM
- spinal cord: 576 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about WNK1.
Disease | AllUniProt
Conditions WNK1 is implicated in, by any mechanism.
- Pseudohypoaldosteronism 2C (PHA2C) MIM:614492
- Neuropathy, hereditary sensory and autonomic, 2A (HSAN2A) MIM:201300
Disease | GeneticClinVar
73 pathogenic / likely-pathogenic of 2,357 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Neuropathy, hereditary sensory and autonomic, type 2A
- Pseudohypoaldosteronism type 2C
- Inborn genetic diseases
- Hereditary neuropathy or pain disorder
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.13
- gnomAD pLI
- 1
- gnomAD missense Z
- 2.16
- DepMap mean gene effect
- -0.8
- DepMap dependency class
- common
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 7% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cell volume homeostasis
- cellular hyperosmotic response
- cellular response to chemokine
- chemokine (C-C motif) ligand 21 signaling pathway
- DNA damage response
- heart development
- intracellular chloride ion homeostasis
- intracellular signal transduction
- lymphocyte migration into lymph node
- membraneless organelle assembly
- monoatomic cation homeostasis
- monoatomic ion transport
- negative regulation of autophagy
- negative regulation of cell-cell adhesion mediated by integrin
- negative regulation of heterotypic cell-cell adhesion
- negative regulation of leukocyte cell-cell adhesion
- negative regulation of pancreatic juice secretion
- negative regulation of protein localization to plasma membrane
- negative regulation of protein ubiquitination
- negative regulation of small GTPase mediated signal transduction
- negative regulation of sodium ion transport
- neuron development
- positive regulation of angiogenesis
- positive regulation of canonical Wnt signaling pathway
- positive regulation of mitotic cytokinesis
- positive regulation of systemic arterial blood pressure
- positive regulation of T cell chemotaxis
- potassium ion homeostasis
- protein insertion into ER membrane by stop-transfer membrane-anchor sequence
- protein phosphorylation
- regulation of monoatomic cation transmembrane transport
- regulation of mRNA export from nucleus
- regulation of sodium ion transmembrane transport
- regulation of sodium ion transport
- signal transduction
- sodium ion transmembrane transport
- T cell receptor signaling pathway
- positive regulation of termination of RNA polymerase II transcription
Molecular functions
- ATP binding
- molecular condensate scaffold activity
- phosphatase binding
- protein kinase activator activity
- protein kinase activity
- protein kinase binding
- protein serine kinase activity
- protein serine/threonine kinase activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Protein kinase domain
- Serine/threonine-protein kinase, active site
- Protein kinase-like domain superfamily
- Serine/threonine-protein kinase OSR1/WNK, CCT domain
- With No Lysine (K) Ser/Thr Protein Kinase
- Serine/threonine-protein kinase WNK, CCTL2 domain
- Protein kinase domain
- Oxidative-stress-responsive kinase 1 C-terminal domain
- WNK CCTL2 domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of WNK1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads WNK1 as an antibody target. Whether an autoantibody or antibody against WNK1 could matter depends on whether native WNK1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
WNK1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label WNK1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...